Iantrek Drive Time Podcast Transistor (https://transistor.fm) https://feeds.transistor.fm/iantrek-drive-time-podcast-7f3ecb82-f436-4eb4-902d-bccb92a10895 A monthly conversation featuring stories from leadership, customer perspectives, and practical insights that connect company-wide work to our daily mission. Each episode is designed to inform, inspire, and equip the team as we show how Iantrek solutions address unmet market needs and improve what matters most: patient outcomes. © 2026 Iantrek 31ac2a43-f6dd-5695-b701-83a9b860bbea yes en Fri, 29 May 2026 11:53:42 -0400 Fri, 29 May 2026 11:54:08 -0400 https://img.transistorcdn.com/yr1EcEwZl-c59j-VacpTgN8WDDWv9ArqQR5cQz4GHMY/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS84MzM4/Nzc5N2Q0M2NmNjAz/YmExNjU5NGRjZWY2/Y2E0Mi5qcGc.jpg Iantrek Drive Time Podcast episodic Iantrek A monthly conversation featuring stories from leadership, customer perspectives, and practical insights that connect company-wide work to our daily mission. Each episode is designed to inform, inspire, and equip the team as we show how Iantrek solutions address unmet market needs and improve what matters most: patient outcomes. A monthly conversation featuring stories from leadership, customer perspectives, and practical insights that connect company-wide work to our daily mission. Iantrek No No Meet Them Where They Are: Drs. Paul Singh and Christine Funke on AlloFlo Adoption, Patient Selection, and Surgeon Support 1 1 Meet Them Where They Are: Drs. Paul Singh and Christine Funke on AlloFlo Adoption, Patient Selection, and Surgeon Support full 2e3a11d1-eedd-43a1-8913-7a36ee40bad6 https://share.transistor.fm/s/4acd2ee1 In this episode of Drive Time from Iantrek, Carey Kelson speaks with Dr. Paul Singh and Dr. Christine Funke about AlloFlo™ Uveo adoption, patient selection, and working in the uveoscleral space. They discuss why the post-MIGS treatment gap matters, which data points resonate with peers, and how AlloFlo has changed their approach to glaucoma care. Their message to the field team is clear: meet each surgeon where they are, identify the barrier, and help them build confidence with the right support.


Show Notes
0:59 — Carey Kelson introduces Dr. Paul Singh and Dr. Christine Funke
1:39 — How both surgeons became involved with Iantrek and AlloFlo™ Uveo
6:29 — Addressing surgeon hesitation around the uveoscleral space
9:00 — CREST data, IOP reduction, medication reduction, and safety discussion
15:27 — Practical guidance for new users: patient selection, cleft creation, and surgeon support


Credits
Host: Carey Kelson, Vice President of Market Development
Guest: Dr. Paul Singh and Dr. Christine Funke
Production: Schaefer Advertising Co.


For internal use only.

]]> In this episode of Drive Time from Iantrek, Carey Kelson speaks with Dr. Paul Singh and Dr. Christine Funke about AlloFlo™ Uveo adoption, patient selection, and working in the uveoscleral space. They discuss why the post-MIGS treatment gap matters, which data points resonate with peers, and how AlloFlo has changed their approach to glaucoma care. Their message to the field team is clear: meet each surgeon where they are, identify the barrier, and help them build confidence with the right support.


Show Notes
0:59 — Carey Kelson introduces Dr. Paul Singh and Dr. Christine Funke
1:39 — How both surgeons became involved with Iantrek and AlloFlo™ Uveo
6:29 — Addressing surgeon hesitation around the uveoscleral space
9:00 — CREST data, IOP reduction, medication reduction, and safety discussion
15:27 — Practical guidance for new users: patient selection, cleft creation, and surgeon support


Credits
Host: Carey Kelson, Vice President of Market Development
Guest: Dr. Paul Singh and Dr. Christine Funke
Production: Schaefer Advertising Co.


For internal use only.

]]> Fri, 01 May 2026 12:29:00 -0400 Iantrek Iantrek 2223 In this episode of Drive Time from Iantrek, Carey Kelson speaks with Dr. Paul Singh and Dr. Christine Funke about AlloFlo™ Uveo adoption, patient selection, and working in the uveoscleral space. They discuss why the post-MIGS treatment gap matters, which data points resonate with peers, and how AlloFlo has changed their approach to glaucoma care. Their message to the field team is clear: meet each surgeon where they are, identify the barrier, and help them build confidence with the right support.


Show Notes
0:59 — Carey Kelson introduces Dr. Paul Singh and Dr. Christine Funke
1:39 — How both surgeons became involved with Iantrek and AlloFlo™ Uveo
6:29 — Addressing surgeon hesitation around the uveoscleral space
9:00 — CREST data, IOP reduction, medication reduction, and safety discussion
15:27 — Practical guidance for new users: patient selection, cleft creation, and surgeon support


Credits
Host: Carey Kelson, Vice President of Market Development
Guest: Dr. Paul Singh and Dr. Christine Funke
Production: Schaefer Advertising Co.


For internal use only.

]]> iantrek, alloflow, ophthalmic surgery, Aqeuous Pathway, opthomology, optometrist No